3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow tipranavir: new trials by email Literature Review of tipranavir trials Research Report on tipranavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI Tipranavir, Darunavir, Ritonavir - HIV Infections | Phase 3 | Terminated | Boehringer Ingelheim | 40 | 2007-09-01 | 2014-05-14 |
| Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation tipranavir, ritonavir - HIV Infections | Phase 3 | Terminated | Boehringer Ingelheim | 11 | 2007-03-01 | 2014-05-14 |
| SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC tipranavir, ritonavir, Optimized Background Regimen (OBR) - HIV Infections | Phase 3 | Terminated | Boehringer Ingelheim | 33 | 2007-02-01 | 2014-06-27 |
HIV Infections (3)
Germany (3) · Italy (3) · Spain (3) · United States (3) · Argentina (2) · Brazil (2) · Canada (2) · France (2) · Belgium (1) · Greece (1) · Portugal (1) · Puerto Rico (1) · Thailand (1) · The Bahamas (1)